News

Sanofi to buy US biopharma group Blueprint for up to $9.5 billion
France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...
Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.
Blueprint Medicines stock was soaring Monday after French drugmaker Sanofi said it had agreed to buy the biotech company for ...
The New York Times22h
New York Times - Top Stories
The drone attacks, one of Ukraine’s broadest assaults of the war, came as another round of cease-fire negotiations was expected on Monday in Istanbul. 5 min read Trump Administration LIVE Trump ...
Sanofi to Buy Blueprint Medicines for Up to $9.5 Billion in Boost to Pipeline — Update
Sanofi agreed to buy Blueprint Medicines for up to $9.5 billion, the French drugmaker's biggest move yet to replenish its drug pipeline since it sold a controlling stake in its consumer-healthcare arm ...
Sanofi to Buy Blueprint for $9.1 Billion Equity Value
Sanofi SA will buy Blueprint Medicines Corp. for $9.1 billion equity value, in a deal that sees the European pharmaceutical ...
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.
If you're OK with accepting a weaker starting yield in exchange for more net gains and capital appreciation than the Schwab U.S. Dividend Equity fund is apt to offer, the Vanguard Dividend ...